Jessica Encinas Mayoral, PhD, discusses preclinical data on an AI-designed BCMA/FcRL5 trispecific antibody in multiple myeloma.
Jessica Encinas Mayoral, PhD
Advertisement
Articles by Jessica Encinas Mayoral, PhD
Jessica Encinas Mayoral, PhD, discusses the design and antigen-independent activity of a BCMA/FcRL5 trispecific antibody in multiple myeloma.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Breakthrough Device Designation to Natera’s Multi-Cancer Early Detection Assay
2
Targeted Approaches in Pancreatic Cancer, Chemo Intensification in CRC Take Center Stage as Key GI Oncology Presentations at ESMO 2026
3
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
4
Next-Generation NAMPT Inhibitors Aim to Revive a Stalled Target in AML and MDS
5